Hjem › Munnhulekreft
Kliniske studier for Munnhulekreft rekrutterer i USA
44 studier for Munnhulekreft rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Atlanta, GA9 studier
- New York City, NY8 studier
- Chicago, IL8 studier
- St. Louis, MO8 studier
- Durham, NC7 studier
- Pittsburgh, PA7 studier
- Milwaukee, WI7 studier
- Kansas City, MO7 studier
- Ann Arbor, MI7 studier
- Houston, TX7 studier
- Richmond, VA7 studier
- Edison, NJ6 studier
- Philadelphia, PA6 studier
- Nashville, TN6 studier
- Kansas City, KS6 studier
- Omaha, NE6 studier
- Oklahoma City, OK6 studier
- Portland, OR6 studier
- Queens, NY5 studier
- Decatur, IL5 studier
- Mountain View, CA5 studier
- Naperville, IL5 studier
- Erie, PA5 studier
- Detroit, MI5 studier
- Champaign, IL5 studier
- Charleston, IL5 studier
- Los Angeles, CA5 studier
- Danville, IL5 studier
- Overland Park, KS5 studier
- Phoenix, AZ5 studier
- Stevens Point, WI5 studier
- Joliet, IL5 studier
- Peoria, IL5 studier
- Bloomington, IL5 studier
- Wausau, WI5 studier
- Cedar Rapids, IA5 studier
- Cape Girardeau, MO5 studier
- Baltimore, MD5 studier
- Cincinnati, OH5 studier
- Toledo, OH4 studier
Etter delstat
- Arizona7 studier
- Arkansas5 studier
- California13 studier
- Colorado8 studier
- Connecticut3 studier
- Florida11 studier
- Georgia9 studier
- Idaho3 studier
- Illinois10 studier
- Indiana5 studier
- Iowa8 studier
- Kansas9 studier
- Kentucky5 studier
- Louisiana3 studier
- Maryland6 studier
- Massachusetts5 studier
- Michigan9 studier
- Minnesota8 studier
- Missouri10 studier
- Montana4 studier
- Nebraska6 studier
- New Hampshire4 studier
- New Jersey8 studier
- New Mexico3 studier
- New York13 studier
- North Carolina9 studier
- North Dakota4 studier
- Ohio14 studier
- Oklahoma6 studier
- Oregon6 studier
- Pennsylvania10 studier
- South Carolina5 studier
- South Dakota4 studier
- Tennessee8 studier
- Texas9 studier
- Vermont3 studier
- Virginia7 studier
- Wisconsin9 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07195734DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05172245Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06736379Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07343596Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07156227Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07441681Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07110142Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06627270Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06819228Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07121595Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT06448026Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT01269190Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT04198766Role of Acetaldehyde in the Development of Oral Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 45 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT05973656Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT06662058Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07460765Integrated Cancer Repository for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.